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Abstract
Background: The forebrain subventricular zone (SVZ) of neonatal mammals contains a large, heterogeneous population of
migratory and proliferating precursors of interneurons and glia. These cell types are produced in large numbers in the
immediate postnatal period, the glioblasts populating the hemispheres with astrocytes and oligodendrocytes, the
neuroblasts migrating to the olfactory bulb to become interneurons. How cell fate decisions are determined or stabilized in
this mixed population is not clear, although previous studies indicate the importance of two transcription factors, Pax6 in
neurons and Olig2 in glia, and suggest there may be reciprocal repression between these genes.
Methodology/Principal Findings: In examining the SVZ of neonatal mouse and rat brain, we find that the very large
majority of SVZ cells express either Pax6 or Olig2, but few express both. We have used in vivo retro- and lenti-virus injections
into the neonatal SVZ and in vitro gene transfer to demonstrate that pax6 over-expression is sufficient to down-regulate
olig2 and to promote a neuronal lineage development and migration pattern in olig2-expressing cells. Furthermore, we
provide evidence that Pax6 binds to the olig2 promoter and that an HEB sequence in the promoter is required for the Pax6
repression of olig2 transcription. Lastly, we constructed a lentivirus to target olig2-expressing cells in the SVZ to trace their
fates, and found that the very large majority developed into glia.
Conclusions/Significance: We provide evidence for a direct repression of olig2 by Pax6. Since SVZ cells can display
developmental plasticity in vitro, the cross-repression promotes a stabilization of cell fates. This repression may be critical in
a germinal zone in which immature cells are highly migratory and are not organized into an epithelium.
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Introduction
During the first few postnatal weeks of rodent forebrain
development, the subventricular zone (SVZ) generates both
neurons and glia [1–5].OHHO This is a region of highly
migratory and proliferative cells, glioblasts populating the
hemispheres with astrocytes and oligodendrocytes, and neuroblasts
migrating to the olfactory bulb, where they become interneurons.
In culture SVZ cells manifest plasticity of fate, since clonal studies
of SVZ cells in vitro show that individual cells can give rise to both
neurons and glia [6]. One would imagine, however, that these
highly migratory cells in the SVZ [7], all exposed to a similar
extracellular environment, would require some mechanism to
restrict fate plasticity in vivo. The mechanisms of cell fate
determination and stabilization in this complex region at this time
are not well understood.
In this study, we have focused on two transcription factors, Pax6
and Olig2 in the neonatal forebrain SVZ. Pax6 has both homeo-
(HD) and paired- (PD) DNAbinding domains [8,9], which contribute
to transcriptional activation (aA-crystallin) [10] or repression
(MMP2, Pax2, and aB1-crystallin) [11–13], depending on the
cellular context and promotes neurogenic cell fates during develop-
ment. [14–16]. The basic helix-loop-helix transcription factor, Olig2,
functions as a transcriptional repressor by dimerizing with E proteins
[17–19]. During forebrain development, Olig2 appears to be critical
for glial cellfate determination. Recently, we found that olig2 specifies
neonatal SVZ cells to produce glial precursors, but not neurons, and
suggested that olig2 expression was sufficient to change a neurogenic
to a gliogenic fate in this population [20].
There is genetic evidence of reciprocal interactions between
Pax6 and Olig2 during spinal cord and forebrain development.
Thus, the pax6-null mouse shows premature glial specification by
the ectopic expression of olig1/2 in spinal cord [21] and the gene
expression pattern of pax6-deficient E15 mouse cortex or
ganglionic eminence shows increased expression of olig2 [22]. In
the E14 pax6 mutant cortex, the normal, ventral olig2 expression
expands dorsally into the ventricular zone in which pax6 is
normally expressed [16] and in an olig1/2 double mutant or olig2
loss of function mouse , the pax6-expressing spinal cord domain V2
expands ventrally to occupy the place of the pMN domain, which
normally expresses olig2 [18,23]. Antagonizing Olig2 function
leads to the upregulation of Pax6 in an acute lesion that activates
Olig2 expression [24]. Finally, overexpressing olig2 in Pax6+
neuroblasts of the adult rodent SVZ converts cells to Olig2+/
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The mechanism(s) underlying this apparent reciprocal expression
remains unknown.
Here, we have examined Pax6 and Olig2 in the neonatal
forebrain SVZ and find individual cells contain Pax6 or Olig2 but
rarely both. Furthermore, we find that Pax6 represses olig2
expression in this population, leading to a downregulation of olig2
and a loss of Olig2 protein. The overexpression of pax6 is sufficient,
in the neonatal SVZ, to repress a gliogenic fate choice and to
promote a neurogenic choice. Finally, we find that the Olig2+
population in the neonatal SVZ develop almost entirely into glia,
suggesting that the olig2 and pax6 populations are not only distinct,
but have different fates, and that a cross-repression between these
two factors is important in stabilizing a neuronal or glial cell fate.
Results
Pax6 and Olig2 have mutually exclusive expression
patterns in the neonatal forebrain SVZ
To characterize the spatial expression patterns of Pax6 and
Olig2 in the neonatal mouse and rat forebrain SVZ, we
performed double immunofluorescence analysis on sections of
P2–4 SVZ and RMS (Fig. 1, and Fig. S1). In both areas and in
both species the cellular localizations of Pax6 and Olig2 appeared
almost entirely mutually exclusive (Fig. 1a–e). Pax6 was
observed in the SVZ and RMS (Fig. 1b). Within the SVZ,
there was a higher density of Pax6+ cells close to the ventricular
surface. Olig2+ cells were found in the SVZ, where they tended
to concentrate in the center and periphery of the region, and in
tissue surrounding the RMS, but few appeared in the RMS itself
(Fig. 1a, b) [20]. There were many Olig2+ cells in the overlying
white matter (Fig. 1c–e), as expected at this time of vigorous
gliogenesis. Pax6+/Olig2+ cells were rare (less than 3% of total
Pax6+ and Olig2+ cells) (Fig. 1f). We compared Pax6 and Olig2
immunostaining with the nuclear marker, DAPI, at this coronal
level (at the level of septal nuclei, where we performed viral
injections, see below). We found that about 85% of the SVZ cell
nuclei were Pax6+ and about 15% were Olig2+. Thus, the large
majority of SVZ cells at this age expressed either one or the other
of these factors (Fig. 1f). The small numbers of non-Olig2+ or
non-Pax6+ cells mostly expressed markers of endothelial cells or
microglia (data not shown).
Figure 1. Mutual exclusive expression of the transcription factors Pax6 and Olig2 in the postnatal SVZ. (a) Pax6+ (green) and Olig2+
(red) visualized in a parasagittal plane of P4 mouse SVZ. (b) Pax6+ (green) and Olig2+ (red) in a parasagittal section of P2 rat brain through the RMS.
Inset depicts the radial migration of glial progenitors and the rostral migration of neuronal progenitors. (c–e) Cells in a coronal section of P2 rat
forebrain. (c) Olig2 (red), (d) merged, and (e) Pax6 (green). Inset (a), (e) depicts the area of photomicrographs shown. (f) Histogram summarizing
percentage of Pax6+ or Olig2+ cells in P4 mouse SVZ. Quantified distributions of cells presented as a percentage of infected cells per brain located in
each area (mean 6 SEM). SVZ; subventricular zone, LV; lateral ventricle, RMS; rostral migratory stream, Olf; olfactory bulb, WM; white matter. Scale
bars: 50 mm.
doi:10.1371/journal.pone.0020894.g001
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performed co-immunostaining with antibodies against cell type
specific markers (Fig. S2). Almost half of the Pax6+ cells were co-
stained with the neuronal ß-tubulin marker, TuJ1 (Fig. S2g, i).
Because of the large amount of TuJ1 signal in this region of the
forebrain, we thought we could obtain better cellular resolution
with isolated cells, and so we isolated SVZ cells from P2 mouse
forebrain and immunostained them for Pax6+, TuJ1+, and olig2
after only 1 hour. About 50% of the Pax6+ cells were also TuJ1+
(data not shown), matching the result from tissue sections, and
double staining for Olig2 and TuJ1+ showed no overlap. A
substantial percentage of the Olig2+ cells were positive for the
NG2 chondroitin sulfate proteoglycan (48% of Olig2+ cells) (Fig.
S2k, l) or ZebrinII (18% of Olig2+ cells) (Fig. S2b, c). Almost
60% of Pax6+ (Fig. S2d, f) and fewer than 5% of Olig2+ cells
(Fig. S2e, f) were positive for RC2, a radial glial cell marker.
Thus, in general, Pax6 localization correlates with early neuronal
development. Olig2 localization is different, although more
complex at this age, since both ZebrinII and RC2 are expressed
by radial glia and ZebrinII is also found in GFAP+ cells of the
neonatal SVZ as well as in developing astrocytes [25,26], so that
neither of these markers necessarily implies a commitment to a
glial lineage.
SVZ progenitors overexpressing pax6 differentiate along
a neuronal lineage in vivo
Previous work in our laboratory showed that the constitutive
expression of olig2 by retroviral infection into neonatal SVZ cells
caused the cells to migrate radially into white matter and cortex
and to differentiate into glia [20]. In contrast, control retrovirus-
infected SVZ cells displayed a mixed pattern: some migrated
radially to become glia, while others migrated anteriorly along the
RMS to become olfactory bulb interneurons (Fig. S3) [7,20]. We
now asked if the expression of pax6 was sufficient to influence SVZ
cell fate in vivo, by performing injections of retroviruses containing
pax6 or pax6(5a)-R128C into the neonatal SVZ to ask if the
expression of these genes alters the fates and migratory patterns of
SVZ cells.
First, immunostaining of P2 rat brain SVZ with the prolifer-
ation marker, Ki67, showed that 71% of Pax6+ and 67% of
Olig2+ SVZ cells are Ki67+. Thus, the large majority of these cells
are cycling and thus amenable to retroviral insertion (Fig. S4a, b)
and there does not appear to be preferential cycling of one
population. To investigate whether pax6 expression induces a
neuronal type migration and differentiation, we generated pax6-
IRES-eGFP and pax6(5a)-R128C-IRES-eGFP expressing retrovirus-
es, the latter representing a DNA binding mutant (30), (Fig. 2 k,l)
and injected them into the P2/3 rat SVZ. At 4dpi of the wild type
pax6 vector, over 90% of the eGFP+ cells were found in the SVZ,
RMS, and olfactory bulb (Fig. 2a–d). eGFP+ cells in the SVZ and
RMS did not show detectable Olig2 (Fig. 2a,b). Most of the pax6
infected cells that had migrated into the RMS expressed the
neuronal marker, TuJ1 (Fig. 2c). Therefore, SVZ progenitors
constitutively expressing pax6 showed a neuroblast-like, tangential
migration pattern and early neuronal differentiation. In contrast,
SVZ cells expressing pax6(5a)-R128C, exhibited a normal
migration pattern, both tangential and radial, into the RMS,
white matter and cortex (Fig. 2e–h). Almost 18% of the eGFP+
cells in the SVZ and white matter were also Olig2+ (Fig. 2e,f).
For quantification of the relative distributions of infected cells, we
examined three comparable parasagittal sections from 4 brains
infected with the pax6 virus and 4 brains infected with the pax6(5a)
R128C at 4dpi (Fig. 2i, j). We observed the same results after
injections of these retroviruses into P3–4 mouse forebrain SVZ
(not shown).
The retroviral data suggest that Pax6 promotes a neuronal fate
in this population. None of the cells expressing retroviral-mediated
Pax6 was positive for Olig2. Immunostaining for the cell death
marker, cleaved caspase3, did not reveal any significant cell loss
resulting from vector injection (Fig. S6a, b). Thus we have no
evidence that overexpression of any of these viruses affected the
cell fates of the population by selectively killing immature glia.
Pax6 targeted to Olig2+ cells in vivo and in culture results
in lower Olig2 levels and a neuronal fate
Because the SVZ contains a heterogeneous population of
dividing cells, retroviruses label both neuroblasts and glioblasts [7].
Despite this heterogeneity, we observed dramatic shifts in cell fates
after pax6 expression by retroviruses (or olig2 expression by
retroviruses, [20]), suggesting that the expression of each
transcription factor was sufficient to produce a loss of the other
factor, followed by the acquisition of glial or neuronal character-
istics. In addition, we used two strategies to target transcription
factor expression to more defined sets of SVZ cells. In the first, we
took advantage of the olig2-Cre mouse to express pax6 in vivo
specifically in Olig2+ cells. In the second, we sorted SVZ cells from
olig2-GFP mice to demonstrate directly that expression of pax6
leads to a loss of Olig2.
For the in vivo studies, we generated a lentiviral vector that
contains a loxp-GFP-stop-loxp-flag-pax6 sequence (Fig. 3f) and
injected this virus into the neonatal SVZ of olig2-Cre mice. (n=5)
For a control, we used a dual reporter virus that contains Ds-red
instead of the flag-Pax6 (Fig. 3a) (n=4). If the pax6 lentiviral vector
incorporates into an olig2-Cre positive cell, then the eGFP-stop
sequence will be excised and the cells will lose eGFP and begin to
express the flag-Pax6. If the vector incorporates into an olig2-Cre
negative cell, then the cell will remain eGFP+ and not express flag-
Pax6. In case of the control lentivirus infection, only the olig2-Cre
positive cells will express Ds-red, whereas the olig2-Cre negative
cells will express eGFP.
First, the control floxed eGFP-stop-Ds-red expressing lentivirus was
injected into the SVZ of P3/4 olig2-Cre mouse brains, and the tissues
analyzed 4 days later. We found eGFP+ cells mostly in the SVZ and
the RMS (,88%) (Fig. 3b, d, k), whereas Ds-red+ cells were
localized to the SVZ (,35%) and overlying white matter and
cerebral cortex (,56%) (Fig. 3c, e, k). All the eGFP+ cells were
Olig2- (Fig. 3b, d), while all the Ds-red+ cells were Olig2+ (Fig.
S5a–c) and Pax6- (Fig. 3c). The Ds-red+ cells showed glial cell
morphologies (Fig. 3e). We found a few eGFP+ cells in the white
matter and lower cortex (,10%of total eGFP+ cells, data not
shown), which are extremely rare with retroviral injections, in our
experience (but see [28], which reported interneurons generated
from dividing SVZ cells inthe newborn mouse frontalcortex). These
lentivirus-labeled cells may not have been proliferating at the time of
injection, since, unlike the retrovirus, the lentiviral backbone can be
incorporated and expressed in non-proliferating cells. Finding these
cells with neuronal characteristics correlates with our unpublished
data with other lentivirus injections into the neonatal SVZ (Personal
communication, R. Ventura). We also found rare Ds-red+ cells in
the RMS (Fig. 3k, l). These cells might represent neuroblasts, or at
least cells migrating as neuroblasts, that were generated from Olig2+
cells in the SVZ, but they were very rare.
Pups were then injected with the floxed eGFP-stop-flag-pax6
lentivirus, and cells visualized by eGFP and/or flag expression 4
days after injection. More than 85%of eGFP+ cells were localized
to the SVZ, RMS, and olfactory bulb, as expected (Fig. 3g, m).
Flag+/Pax6+ cells, which were Olig2+ at the time of infection,
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RMS (,41%) and olfactory bulb (,2%) (Fig. 3m,n). The flag+
cells were Olig2- in SVZ (Fig. 3h) and RMS (Fig. 3i). In
addition, most of the flag+/Pax6+ cells in the RMS and olfactory
bulb also expressed the neuronal marker TuJ1 (Fig. 3j, Fig. S5d).
These observations strongly suggest that the expression of pax6 in
an Olig2+ cell can alter the cell lineage from glial to neuronal. No
increased cell death was observed in olig2-Cre mice injected with
control or flag-pax6 viruses (Fig. S6c–f). For quantification of the
relative distributions of infected cells, we used a sampling of three
comparable parasagittal sections from 4 brains injected with
control lentivirus and 3 brains injected with pax6 lentivirus.
(Fig. 3k, m)
In the second strategy, we FAC sorted SVZ cells from P4 olig2-
GFP mice, cultured the cells, and analyzed them by subsequent
immunofluorescence staining (Fig. 4). Immunostaining revealed
that the Olig2-eGFP+ sorted cells did not contain detectable Pax6
even after 7 days in culture (Fig. 4a, b). Next, to determine
whether pax6 can repress endogenous Olig2 expression in these
cells, we transfected the flag-pax6 expression construct (p3xFLAG-
Pax6) 2 days after plating the cells. Cultures were fixed and
immunostained with anti-flag and anti-Olig2 antibodies 3 days
later. We observed that the Pax6-flag+ cells showed very low or
undetectable levels of Olig2 (Fig. 4d). Such a loss of Olig2 was not
observed after cells were transfected with a control HC-red
construct (Fig. 4c).
In Silico approach identifies putative Pax6 binding sites
on the promoter regions of olig2
One possible conclusion from the above studies is that Pax6
represses olig2. To investigate putative transcriptional interactions
between the olig2 promoter and Pax6, we first used an in silico
approach to identify transcription factor binding sites in the 59
upstream promoter sequences of olig2. Four effective transcription
factor binding sites were predicted in the olig2 promoter sequence,
with above 90%identity across 5 vertebrate species (Fig. 5c). Two
of them are Pax6 and HEB binding sites around 1.7 kb upstream
of the transcription start site (TSS); the other is a generic Pax
binding site (about 2.7 kb upstream of TSS), and the last is a
TATA binding site, which is near the TSS (Fig. 5c, d).
Figure 2. SVZ cells infected with retroviral-expressed pax6 differentiate along a neuronal lineage in vivo. Retroviruses were injected into
the SVZ of P2 rat brains (n=7 for each condition) analyzed 4 d later. (a–d) pax6-IRES-eGFP infected cells migrated into the RMS. All eGFP+ cells are
Olig2- in SVZ (a) and RMS (b) and express TuJ1 in the RMS (c). (d) Distribution of cells. (e–h) pax6(5a) R128C-IRES-eGFP infected cells exhibit a normal
(mixed glial and neuronal) migration pattern. (e) Olig2+/eGFP+ or Olig2-/eGFP+ infected cells are observed in SVZ. (f) White box shows Olig2+/eGFP+
cell. (g) Yellow box shows Olig2-/eGFP+ cells. (h) Distribution of cells. (i) Histogram analysis of the effects of pax6 and pax6(5a) R128C infection on
migratory behavior, presented as the percentage of infected cells per brain located in each area (mean 6 SEM).
*, by student’s t test p,0.05,
**,
p,0.01.Scale bars, 50 mm.
doi:10.1371/journal.pone.0020894.g002
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The SVZ of P3/P4 olig2-Cre mouse was stereotactically injected with lentiviruses expressing loxp-GFP-stop-loxp-dsred (control) (n=5), or loxp-GFP-stop-
loxp-flag-pax6 (Pax6-lenti) (n=6) and brains analyzed 4 days later. (a, f) Schematics of control (a) and Pax6-lenti (f) constructs. (b–e) eGFP+ cells
infected by control-lentivirus, which were Olig2- at infection, migrated tangentially, whereas dsred+ cells, which were Olig2+, showed radial
migration. (b) eGFP+ cells were Olig2- in SVZ. (c) Ds-red+ cells located in WM, SVZ and Ctx, are Pax6-. (d) eGFP+ cells were Olig2- in RMS. (e) Ds-red+
cells showed glial morphology in WM. (g–j) Both eGFP and flag-tagged Pax6 expressing cells by Pax6-lenti virus migrated tangentially. (g) eGFP+ cells
were Olig2- in SVZ. Flag+ cells, which were Olig2+ at infection, were Olig2- in SVZ (h) and RMS (i). (k, m) Histogram analysis of the effects of control (j)
or Pax6-lentivirus (l) on migration. Quantified distributions of cells presented as a percentage of infected cells per brain located in each area (mean 6
SEM).
*, by student’s t test p,0.05,
**, p,0.01. (l, n) Schematic distribution of SVZ cells expressing control (l) or Pax6 (n) and site of injection. Scale bars,
50 mm.
doi:10.1371/journal.pone.0020894.g003
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promoter regions in vivo
Based on the in silico findings, we predicted that Pax6 can
associate with the olig2 promoter. To confirm whether Pax6 binds
to the olig2, we performed chromosomal immunoprecipitation
(ChIP) experiments with lysates from P4 mouse forebrain (Fig. 6a).
The same experiment with P2 rat SVZ gave the same result (not
shown). By immunoprecipitation with a Pax6 antibody, followed
by PCR with primers that flanked the putative Pax6 binding
sequence in the olig2 promoter, we amplified that specific Pax6
binding DNA sequence (Fig. 6a). A negative control and a control
immunoprecipitation with IgG did not result in the amplified
sequence. Furthermore, when we used a primer set that covers the
region of the more generic Pax binding site, we did not find any
amplified sequence.
Pax6 represses olig2 transcription and leads to lower
Olig2 protein levels
To determine if Pax6 binding influenced transcriptional
changes of olig2, we performed luciferase reporter assays. We
made a firefly luciferase construct that contains almost 2.5 kb
upstream of the olig2 TSS (Olig2-pLuc MCS), including the putative
Pax6 binding site (Fig. 6b), and co-transfected this construct with
a pax6 (p3XFLAG-pax6)o reGFP (pEGFP) (as control) expression
construct into the oligodendrocyte precursor cell line, Oli-Neu.
This line has high endogenous Olig2 levels but no detectable Pax6
(data not shown). The effects of Pax6 overexpression were
determined in the presence of 0, 50, or 100 ng of the pax6
expression construct by detecting luciferase activity after 48 hrs.
We found that 100 ng of pax6 construct led to over a 75%decrease
in Olig2-pLuc MCS transcriptional activity, compared to basal Olig2
pLuc activity (p,0.01) (Fig. 6d). Overexpression of a Pax6 that
does not bind DNA (binding site mutant construct, Pax6(5a)
R128C [29], did not repress olig2 promoter-luciferase activity
(Fig. 6d).
To examine the Pax6 and HEB binding sequences in the olig2
promoter further, we also generated two more Olig2-pLuc
constructs. In one, the 3 most highly conserved base pairs of the
Pax6 core-binding site were mutated and in the other, the 3 most
highly conserved base pairs in the HEB site were mutated
(Fig. 6b, c). Mutation of the Pax6 binding site resulted in
luciferase activity as high as with the Olig2-pLuc vector in the
absence of Pax6 (recall that the Oli-Neu cell line does not contain
detectable Pax6) (Fig. 6d). Furthermore, expressing Pax6 did not
diminish this activity (Fig. 6d). This result implies that the
inhibition of Olig2-pLuc transcription that we observed in the
presence of Pax6 (above) is a direct result of Pax6 binding to the
Pax6 site.
Mutation of the HEB binding core sequence markedly
decreased the baseline transcriptional activity of olig2, reducing it
to that observed in the pLuc control (the pLuc vector without the
Figure 4. In vitro overexpression of Pax6 inhibits cell intrinsic expression of Olig2. The olig2-GFP mouse SVZ was manually dissected from
P4 pups. Tissue was washed in PBS, then incubated to 0.05%trypsin/0.53 mM EDTA (Invitrogen) at 37uC for 10 min and triturated. Trypsin was
neutralized with PBS with 2%FBS. Neutralized cells were filtered and separated with 4%glucose PBS solution. Cell sorting was performed in the
Columbia FACS facility using a modified triple laser FACS instrument and Summit software (DAKO) or DIVA software (BD Biosciences). The FlowJo
program (Tree Star) was used for flow cytometry data analysis. Sorted Olig2-GFP cells were attached on glass slides and cultured in B1O4 conditioned
medium (Hunter and Bottenstein, 1990; Hunter and Bottenstein, 1991) mixed 1:3 with DMEM and then transfected with either pax6 or control eGFP
expression constructs. Infected cells were kept in culture with basal media (DMEM, N2, T3, and penicillin/streptomycin/amphotericin) for 2d and then
fixed in 4%paraformaldehyde, stained and analyzed by fluorescence microscopy. (a, b) After sorting, Olig2-eGFP positive cells were plated, incubated
7 days and immunostained with antibodies against Pax6. Virtually all of Olig2-eGFP+ cells (a) are Pax6-(b). eGFP immunostaining in green, Pax6 in red.
(c) Sorted Olig2-eGFP cells were transfected with control Hcred vector. 48 hrs after transfection, immunostaining was done with anti-Olig2 antibody.
Hcred immunostaining in red, Olig2 in Cy5. (d) Sorted Olig2-eGFP cells were transfected with the vector expressing flag-tagged wt Pax6. Each result
was obtained by three independent experiments. Double immunostaining with anti-Olig2 and Pax6 antibodies demonstrates that transfected cells
were Pax6+ but Olig2-. Olig2 immunostaining in Cy5, Pax6 in red. Scale bars, 50 mm.
doi:10.1371/journal.pone.0020894.g004
Pax6 Promotes a Neurogenic Fate to SVZ Glioblasts
PLoS ONE | www.plosone.org 6 June 2011 | Volume 6 | Issue 6 | e20894olig2 promoter) (Fig. 6d). This result indicates that the HEB site is
required for the high basal olig2 transcription in these cells. When
we expressed Pax6 along with the HEB site mutant construct, we
saw a small increase in luciferase activity over the low control level
(Fig. 6d). This may suggest that Pax6 has a weak activator effect
in the context of the mutated HEB site. The more important
conclusion is that the Pax6 inhibition of olig2 transcription requires
an intact HEB binding site. We do not yet know the mechanism
underlying this inhibition, but suggest possibilities below (see
Discussion).
To determine if the transcriptional repression resulted in lower
levels of the Olig2 protein, we examined the endogenous 32 kDa
Olig2 protein levels in Oli-Neu cells after transfection of a flag-
tagged pax6 construct (p3xFLAG-Pax6)( Fig. 7a). Western blotting
revealed that the Olig2 protein level was decreased more than
80%by the overexpression of pax6 by 72 hrs after transfection
(p,0.01). In contrast, Olig2 levels were not decreased after
overexpression of a control eGFP construct or the Pax6 DNA
binding site mutant, Pax6(5a) R128C construct (Fig. 7a). We also
investigated Olig2 protein expression levels by immunofluores-
cence staining for Olig2 after transfection of flag-tagged pax6
construct into Oli-Neu cells (Fig. 7b). Almost 77%of cells
transfected with the pax6 construct appeared Olig2- or weak
Olig2+ (p,0.01), whereas cells transfected with a control GFP
empty vector or the Pax6(5a) R128C vector sustained their
endogenous Olig2 levels (Fig. 7b, c).
Discussion
While Pax6 acts mostly as a transcriptional activator, there are
several reports of transcriptional repressor activity, which is
independent of the Pax6-transactivation domain [11–13]. In
addition, Tang et al., [30] determined a modest intrinsic repressor
activity of Pax6. In our study, we provide evidence for
transcriptional repression of olig2 transcription by Pax6. We found
that a consensus Pax6 site and an HEB site on the olig2 promoter
are separated by only about a dozen base pairs. Our luciferase
data strongly suggest that a putative activator complex binds to the
HEB site and activates olig2, since a mutation in the HEB binding
site decreases the basal olig2 transcription to control levels. (Fig. 6)
However, mutating the Pax6 binding site did not result in
increased olig2 transcriptional activity. Thus, it is possible that
Pax6 represses olig2 transcription by inhibiting the binding of a
transcriptional-promoting complex at the HEB site or recruits a
transcriptional-inhibiting complex instead (Fig. 8). Further study
of this promoter site and a definition of the transcriptional
complexes that bind to that site are in order. Here, we showed our
results with using both mice and rats, those results suggest that
Pax6 and Olig2 expression and function in both species are similar
at the same developmental time stage.
The majority of Ki67+ perinatal SVZ cells that we think of as
neurogenic and/or gliogenic progenitor cells either express Pax6
or Olig2 (Fig. S4). Olig2 expression has been reported in a subset
Figure 5. Predicted Pax6 binding sites on the olig2 promoter region. (a, b) Graphical representations of consensus sequence for Pax6 (a)o rE
box (b) binding site, used as a matrix for prediction. (c) Schematic of predicted transcription factor binding sites of olig2 promoter region. Colored
boxes represent transcription factor binding sites. Pax6 binds to the blue Pax6 region. (c, d) Sites are selected after comparing the sequence
conservation across 5 vertebrate species. Scores from the transcription factor binding site analysis for pax6 gene promoter region used Match
program in Transfac database software package.
doi:10.1371/journal.pone.0020894.g005
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PLoS ONE | www.plosone.org 7 June 2011 | Volume 6 | Issue 6 | e20894Figure 6. Pax6 represses olig2 transcription by binding to the promoter region of the olig2 gene. (a) Chromatin immunoprecipitation in
P4 mouse forebrain lysate indicates that Pax6 binds to the promoter region of olig2. ‘‘Input’’ refers to 0.1%pre-immunoprecipitation input, ‘‘w/o Ab’’ is
control without primary antibody, ‘‘w/o lysates’’ is control without lysate, ‘‘IgG’’ is immunoprecipitation with a control IgG, which serves as negative
control. (b) Schematics of reporter gene vector. Normal Olig2 promoter region (Olig2-Luc) and Pax6 or HEB binding core sequences mutated
promoter region (Pax6 or HEB Binding mut-Luc) are placed upstream of the firefly luciferase gene. (c) Mutated Pax6 or HEB binding site sequences.
(d) Reporter assay reveals that Pax6 acts as a transcriptional repressor to olig2. Overexpression of pax6 inhibits the olig2 promoter reporter gene
transcription, while the DNA binding site mutant Pax6(5a) R128C does not. A mutation in the Pax6 binding site abolishes the repression effect.
Mutation in the HEB binding site abolishes luciferase activity, with or without Pax6. Each result represents a mean 6 S.D. of three independent
experiments carried out in triplicate.
*, by student’s t test p,0.05,
**, p,0.01.
doi:10.1371/journal.pone.0020894.g006
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adult mouse SVZ, and these cells have gliogenic potential [25,31].
Some of the type C cells in the adult SVZ express Pax6 and
generate olfactory interneurons in the adult SVZ [32]. It is not
clear if B, C, and A cells can be clearly defined in the neonatal
SVZ, but the large cycling population is likely to be most similar to
a mix of C and A cells.
We don’t know yet if the Pax6+ and Olig2+ positive cells in the
neonatal SVZ are equivalent to C cells in the adult SVZ. In the
perinatal SVZ, most of the Pax6 cells expressed an early
neuroblast marker, TuJ1, whereas the Olig2+ cells were TuJ1-
and instead predominantly expressed NG2 and ZebrinII,
suggesting that they are glial precursors (28). We also find radial
glial cells, defined by a long, radial morphology and the expression
of RC2 to be Pax6+ or Olig2+ [20] but not both. We cannot at
this time conclude that the Pax6+ radial glia (or progenitor cells)
are neurogenic and the Olig2+ radial glia (or progenitor cells) are
gliogenic in this perinatal time, but our findings are consistent with
previous data supporting Pax6 as an intrinsic neuronal fate
determinant [16], and Olig2 as a glial fate determinant [20].
Our observations in this and in a previous study [20] indicate
that neonatal SVZ cells are developmentally plastic enough to
change their Pax6 or Olig2 expression levels after overexpression
of the other factor and that this change appears to be sufficient to
promote the early acquisition of neuronal or glial fates,
respectively, and change the migration patterns appropriately.
Cell fate and migration patterns are strongly linked for SVZ cells,
since immature glia migrate radially into overlying white matter,
cortex, and striatum, whereas immature neurons migrate into and
along the RMS. However, some cortical GABAergic interneurons
Figure 7. Overexpression of Pax6 decreases Olig2 protein levels. (a) Proteins for Western blotting were analyzed 24, 48, and 72 hrs after
transfection. (a) Oli-Neu cells were transfected with flag-tagged WT Pax6 (WT), Pax6(5a)R128C (128), or eGFP control vector (-). (b) Immunostaining
analysis 72 hrs after transfection shows that overexpressed Pax6 decreases Olig2 levels in Oli-Neu cells. (c) Histogram summarizing percentage of
Olig2+ cells in Oli-Neu cells after transfection. Each result represents a mean 6 S.D. of three independent experiments. At each time point (24, 48,
72 h) we compared the Olig2 protein band seen after transfection with the WT Pax6 vector and the mutant Pax6 vector with the Olig2 band seen
after transfection with the control vector.
* by student’s t test p,0.05,
** by student’s t test p,0.01.
doi:10.1371/journal.pone.0020894.g007
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[28], although it was not reported whether these cortical
interneurons expressed pax6. Glial precursor migration appears
to occur along radial glial processes and axons [34,35], whereas
neuronal precursor migration takes place in a ‘‘chain migration’’
in which neuroblasts migrate over each other [3]. This coupling of
fate and migratory patterns may be determined by Pax6 and
Olig2, but we do not yet know if there are specific adhesion
molecule or migration genes that are regulated by these
transcription factors. Studies in non-CNS development have
identified several adhesion molecule genes regulated by Pax6
[36], but it is not known if any of these plays a role in specifying
glial vs. neuronal migration. The analysis of genes downstream of
pax6 and olig2 may shed light on the molecular coordination
between fate determination and migration patterns.
In the adult CNS there is evidence for neuronal-glial fate
plasticity. Recently, Jablonska et al.(36) showed that lysolecithin-
induced demyelination in the white matter overlying the adult
SVZ caused Pax6+/Glutamic acid decarboxylase 65+/Double-
cortin+ precursor cells in the adult SVZ to switch their fates from
olfactory interneurons to oligodendrocytes and to migrate into the
overlying corpus callosum. We do not know if the cells require
Pax6 loss and Olig2 expression to switch fates, but if so, a switch
implies neuronal-glial plasticity of Pax6+ cells and is consistent
with our observations in the neonatal SVZ.
What might be the function of this cross-repression in the
neonatal SVZ? This is an area of high cell density and active cell
migration that generates both neurons and glia. In addition, the
neonatal forebrain SVZ shows the expression of factors that
regulate neuronal and glial fate decisions, such as Shh and BMP (in
situ hybridization data, S. Ivkovic personal communication).
However, it appears unlikely that olig2 and pax6 actually regulate
the initial fate determination of SVZ cells. Indeed, SVZ cells may
originate from precursors already expressing pax6 or olig2. The
migratory cell population of the neonatal SVZ cells has at least two
sources: 1. Precursors generated ventrally in embryonic times that
migrate into the dorso-lateral SVZ [26] and 2. radial cells of the
dorsal telencephalon, which generate neurons and glia in the early
postnatal brain [38]. We have found Pax6+ and Olig2+ cells in
this dorsal radial cell population, defined by RC2 expression and
morphology, and there is no overlap between the expression of the
two proteins in the RC2+ population ( [20] and this paper). Thus,
it is possible that a glial vs. neuronal fate determination takes place
at an earlier, radial progenitor stage. We would have to trace the
fates of the Pax6+ and Olig2+ radial populations to confirm this
idea. However, since the expression of pax6 and olig2 is sufficient to
force glial precursors to begin to differentiate along a neuronal
developmental pathway, and force neuronal precursors to begin to
differentiate along a gliogenic pathway, respectively, these two
transcription factors must be situated at critical positions in a
Figure 8. A model depicting the possible olig2 regulation mechanism by Pax6. (a) In this model, Pax6 protein represses the olig2 gene by
binding on the olig2 promoter region. This binding either could inhibit the binding to an activator to the HEB binding site or recruit a repressor to the
HEB site. Either would inhibit olig2 and promote neurogenesis. (b)Without Pax6, unknown activator complex is recruited and activates olig2
transcription, leading to higher Olig2 levels and gliogenesis.
doi:10.1371/journal.pone.0020894.g008
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interneuron and glial phenotypes.
How specific is olig2 expression for a committed glial lineage in
the neonatal SVZ? Could olig2 be expressed during an early stage
of neuroblast development? For example, could olig2 be expressed
briefly in transit-amplifying cells that will eventually differentiate
into Pax6+ neuroblasts? Our observations with the floxed eGFP-stop-
Ds-red expressing lentivirus in the olig2-Cre mouse brains suggest
that this is not the case. If an Olig2+ stage were an obligatory step
in the early development of neuroblasts, then we would have
expected to see Ds-red+/Pax6+ cells in the RMS. Such cells were
very rare, however, and it will require a much more extensive
analysis to characterize them. Indeed, the vast majority of Ds-red+
cells were also Olig2+ and had migrated radially like glioblasts.
In thinking about the function of Pax6 and Olig2 cross-
repression, one needs to consider that, despite the apparent
committed fates of glioblasts and neuroblasts in the normal
neonatal SVZ in vivo, these cells still retain developmental
plasticity. For example, neonatal SVZ cells labeled by retrovirus
in vivo can generate clones containing both neurons and glia when
removed from the SVZ and grown in culture [6]. Adult SVZ cells
that are Pax6+ can become glia after white matter demyelination
[37]. Once an early neuronal vs. glial fate decision has begun, this
cross-repressive feedback system would serve to stabilize a cell’s
fate and inhibit other fates. This would prevent the development of
immature cells with mixed neuronal and glial characteristics, for
example. Thus, Pax6 and Olig2 could form a reciprocal-repression
feedback loop to keep an immature cell firmly headed along




Olig2-GFP and Olig2-Cre mice (B.G. Novitch and T.M. Jessell,
unpublished observation) were generated by disruption of the
coding region of Olig2 with an IRES-eGFP and IRES-Cre
cassette. BAC clone PAX6-GFP mouse was a gift from Prof. David
Price, Univ. of Edinburgh. We also used Sprague Dawley rats for
retrovirus injection. All animal work was performed according to
Institutional Animal Care and Use Committee guidelines of
Columbia University. Mouse protocols #AAAA4951,
AAAA5839; rat protocols AAAA4417, AAAA8919 were approved
by the Institutional Animal Care and Use Committee of Columbia
University.
Immunohistochemistry
All tissue sections and antibodies are prepared as described
previously (Marshall et al., 2005). Primary antibodies were rabbit
anti-Pax6 (Chemicon, 1:1000), goat anti-Pax6 (Sigma, 1:1000),
rabbit anti-Olig2 (Chemicon, 1:1000), guineapig anti-Olig2
(1:20,000, gift of David Rowitch, UCSF), rabbit anti-Olig2
(ABCAM, 1:1000), mouse anti-ß-tubulin (TuJ1) (Covance,
1:200), mouse anti-RC2 antibody (Developmental Studies Hy-
bridoma Bank, 1:5), rabbit anti-Ki67 (ABCAM, 1:500), mouse
anti-flag (Sigma, 1:200), rabbit anti-flag (Sigma, 1:100), and mouse
anti-ds-red (BD Biosciences, 1:1000).
Microscopy
Histological sections and cell cultures were examined and
photographed using a Zeiss Axiophot 200 fluorescence microscope
equipped with an Axiocam (Zeiss, Thornwood, NY) and Openlab
imaging software (Improvision, Lexington, MA). Micrographs
were further processed into composite figures using Adobe
Photoshop.
In silico approach
The sequence that spanned 10,000 bps upstream to 200 bp
downstream of the olig2 or pax6 gene’s transcriptional start site
(TSS) was extracted from the University of California at Santa
Cruz Genome Bioinformatics website (http://genome.ucsc.edu).
TRANSFACH Professional 8.3 package (http://www.biobase.de/)
was used for the computational identification of transcription factor
binding sites. In the matrix search for transcription factor binding
sites, only high quality matrices are applied to the MATCH
TM 2.2
program to minimize false positives. A phylogenetic footprinting
method that is based on the fact that biologically important
regulatory elements have been selectively conserved during the
evolution was applied to the results from the matrix search. In this
analysis, ClustalW was used for multiple alignments between the
olig2 promoter sequences from multiple species.
Chromatin immunoprecipitation assay (ChIP)
The Millipore ChIP assay protocol was used for P2 rat or P4
mouse forebrain cells using the rabbit anti-Pax6 antibody, or a
control normal rabbit IgG (Santa Cruz). PCR amplification was
performed using following primer sets.
olig2 promoter Pax6 binding site: Fwd 59CAAGAGTGGTCC-
TCACATGC39
Rev 59CCTTCTGGGGCATTGTTTT 39
olig2 promoter Pax binding site: Fwd 59AATAGGGAACCAG-
GGAATCG 39
Rev 59CTCCTTCAACCAGGAAGACG39
Construction of reporter plasmids, and luciferase reporter
assay
olig2 promoter Luciferase plasmid was constructed by inserting





The olig2 promoter insert was amplified by PCR using primers,
digested with BamHI, and SalI, inserted into the respective site of
pLuc-MCS (Stratagene). Olig2 promoter luciferase constructs with
a 3 bp point mutation either in the Pax6 or the HEB binding
sequence were generated using QuickChangeH Site Directed
Mutagenesis Kit (Stratagene) and the following primers, shown











For the luciferase assay in the oligodendrocyte precursor cell
line Oli-Neu (gift of Dr. Jacqueline Trotter, Univ. of Mainz), 50 ng
of olig2 promoter reporter plasmid DNA was co-transfected into
2610
4 cells with 0, 50, and 100 ng of pax6 expressing p3XFLAG-
Pax6 (gift from Dr. Cvekl, Albert Einstein College of Medicine),
10 ng of Renilla luciferase expressing pRL-TK (Promega), and
pEGFP (Clontech) for adjusting transfected DNA amount into
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domain mutant construct, Pax6(5a)R128C (from Dr. Cvekl)
instead of using the Pax6 expression vector.
Western Blot Analysis
Cell lysates were prepared in RIPA buffer (Sigma) 24, 48, and
72 h after transfection. Equal amounts of lysates (15 mg protein)
were resolved on a NuPAGE Novex 10%Bis-Tris gel (Invitrogen).
Primary antibodies used were: rabbit anti-Olig2 (ABCAM,
1:1000), rabbit anti-Pax6 (Chemicon, 1:1000), mouse anti-ß-
Tubulin (Santa Cruz, 1:1000). After stripping the Olig2 or Pax6
antibodies, gels were re-probed with anti-a–tubulin for normali-
zation.
Viral vectors and virus preparation
For Pax6 retrovirus, all fragments encoding Pax6 or mutant
Pax6 cDNAs were subcloned into the pQCXIX (Clontech).
Coding fragments were as follows: m-pax6 (BamH1 and HindIII
fragment from p3xflag-Pax6), m-pax6(5a) R128C (BamH1 and
HindIII fragment from p3xflag-Pax6(5a) R128C). The pax6-R128C
encodes a mutant protein that does not bind DNA (30).
To generate lentivirus expressing control eGFPstop-loxp-IRES-
dsred lenti virus, we first inserted the coding sequence (NheI and
NotI fragment from p212 pCMV-EGFP/RFP (addgene)) into the
pLion (addgene). To generate loxp-eGFPstop-loxp-IRES-flag-pax6,





We cleaved the control lentivirus with NheI and NotI and ligated
the flag-tagged Pax6 insert (SacII and NotI fragment). Viral stocks
were concentrated by centrifugation and titered to 1610
6 cfu/ml
using 3T3 cells 48 h post-transfection.
Retrovirus generation was described previously [20]. For
lentivirus, lentiviral vectors were cotransfected with pCMV-
dR8.2 dvpr and pCMV-VSVG into HEK-293T (Clontech) cells
using Lipofectamine 2000 (Invitrogen). Viral stocks were concen-
trated by centrifugation and titered to 1–3610
5 cfu/ml using 293
cells 48 h post-transfection.
Viral injections
Retroviral injections into neonatal rat pups were done as
previously described [20]. Lentiviral injections were performed on
P3 olig2-Cre mice. After anesthetization of P3 mouse by
hypothermia, 0.1 ml of lentivirus suspension was injected unilat-
erally at a rate of 0.02 ml/min using a 10 ml Hamilton (Reno, NV)
syringe. Coordinates used for mouse pups was 0 mm bregma line,
0.8 mm lateral, and 1.5 mm depth.
Mouse brain cell dispersion and Flow Cytometry
Detailed methods are described in the Legend to Figure 4.
Statistical analysis
Statistical analysis was done with the unpaired Student’s t-test; n
corresponds to the number of all cells, brains or data analyzed. For
the injections, the S.E.M. represents the variance between different
i n j e c t i o n si n t od i f f e r e n ta n i m a l s ;t h a ti s ,as i n g l ed a t ap o i n tr e p r e s e n t s
all of the fluorescence-positive cells counted in one animal.
Supporting Information
Figure S1 Pax6 and Olig2 express exclusively in the
postnatal p2 rat brain SVZ region. Pax6 and Olig2 show
exclusive expression pattern in neonatal SVZ, as indicated by
immunofluorescence staining of P2 rat brain. (a–c) Micrograph of
Olig2+ (a), Pax6+ (c) or merged (b) cells at coronal plane of
neonatal P2 rat SVZ. White box depicts diagram of coronal plane
neonatal SVZ. Red inset represents the site of picture taken on the
diagram of coronal brain plane. Pax6 immunostaining in green,
Olig2 in red. SVZ; subventricular zone, LV; lateral ventricle,
WM; white matter. Scale bars, 50 mm.
(TIF)
Figure S2 Cell marker expression of Olig2+ and Pax6+
SVZ cells. Pax6 or Olig2 expression in Zebrin II+ (a, b), RC2+
(d, e), TuJ1+ (g, h), or NG2+ (j, k) SVZ cells, as indicated by
immunostaining of P4 mouse parasagittal sections. (c, f, i, l)
Histogram summarizing percentage of marker positive cells
(Zebrin II + in (c), RC2+ in (f), TuJ1+ in (i), and NG2+ in (l))
in either Pax6 (left lane) or Olig2 (right lane) positive populations
in P4 mouse postnatal SVZ. Inset (m) depicts the area of
photomicrographs shown. SVZ; subventricular zone, LV; lateral
ventricle, WM; white matter. Scale bars 50 mm.
(TIF)
Figure S3 Control retrovirus infected cells exhibit a
normal (mixed glial and neuronal) migration pattern.
Retrovirus was injected into the SVZ of P2 rats (n=7) and
analyzed 4d later. (a) Schematics of control retroviral constructs.
(b, c) pq-IRES-eGFP infected cells migrate radially migrate into
WM or remain in the SVZ (b) or tangentially into the RMS (c).
(d) Diagrammatic distribution of infected cells and injection site.
(e) Histogram analysis of the effects of control retrovirus infection
on migratory behavior, presented as the percentage of infected
cells per brain located in each area (mean 6 SEM). (f, g)
Schematics of pax6 (f), and pax6(5a) R128C (g) retroviral
constructs. The numbers of infected cells per brain ranged from
40 to 67. All data made with 4 dpi sections. Scale bars, 50 mm.
(TIF)
Figure S4 Pax6 or Olig2 protein expresses within
proliferating progenitor cells in postnatal SVZ. (a, b)
Proliferating cells in the parasagittal sections of the P4 mouse brain
SVZ were detected using an antibody against proliferating cell
marker Ki67. (a) Pax6+ cells were observed within proliferating
(Ki67 positive; green) SVZ region. Pax6 immunostaining in red,
Ki67 in green. (b) Olig2+/Ki67+ cells were detected within the
SVZ region. Olig2 immunostaining in red, Ki67 in green. SVZ;
subventricular zone, LV; lateral ventricle WM; white matter. Scale
bars, 50 mm.
(TIF)
Figure S5 Lentiviral derived flag is expressed exclu-
sively by SVZ-derived neuronal lineage cells. (a–c) Ds-red
+ cells (a) were overlapped with Olig2 (c) in SVZ. Panel (b) shows
merged cells at 4 dpi. White arrows point Ds-red+/Olig2+ cells.
Olig2 immunostaining in Cy5, Ds-red in red. (d) In RMS, flag
positive cells were merged with neuronal marker TuJ1 4 dpi after
stereotactic injection of Pax6 lentivirus into P2 mouse SVZ. TuJ1
immunostaining in Cy5, flag in red. SVZ; subvenrticular zone,
LV; lateral ventricle, RMS; rostral migratory stream. Scale bars,
50 mm.
(TIF)
Figure S6 Virus injected brains did not show any
distinct cell death. (a, b) Cell death of retrovirus injected
brains was determined by immunofluorescence staining with a
cleaved caspase 3 antibody (cCas3). eGFP immunostaining in
green, cCas3 in red. Micrograph of eGFP and cCas3 immuno-
reactive cells in a parasagittal plane of postnatal rat SVZ injected
Pax6 Promotes a Neurogenic Fate to SVZ Glioblasts
PLoS ONE | www.plosone.org 12 June 2011 | Volume 6 | Issue 6 | e20894with retro pax6-eGFP (a)o rpax6(5a) R128C-eGFP virus (b). (c, d)
Micrograph of either eGFP (c) or Ds-red (d) and cCas3
immunoreactive cells at parasagittal plane of control lentivirus
injected postnatal mouse SVZ. eGFP immunostaining in green,
Dsred in red, and cCas3 in Cy5. (e, f) Micrograph of either eGFP
(e) or flag (e) and cCas3 immunoreactive cells at parasagittal plane
of Pax6-lenti virus injected postnatal mouse SVZ. eGFP
immunostaining in green, flag in red, and cCas3 in Cy5. SVZ;
subventricular zone, LV; lateral ventricle, WM; white matter.
Scale bars, 50 mm.
(TIF)
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